A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic, were linked to a 33% lower risk of dementia.

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so. Meanwhile, Medicare currently covers GLP-1 drugs for people with a ...

Shares of Novo Nordisk ( NVO 2.48%) are falling this week, down 33% as of 3:27 p.m. ET on Friday. The drop comes as the S&P ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to have contributed to something that’s helped so many.

Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

As a reporter, I've covered all things GLP-1. Here's what I've learned. From protein hacks to thinness myths, my reporting journey has been full of surprises.

Among employers with 500 or more workers, 51% said they planned to increase cost-sharing in 2026, including raising deductibles and maximum out-of-pocket costs for workers ...

Concern over the cost of GLP-1 weight-loss drugs like Novo Nordisk's Wegovy has surged ... While some employers have covered GLP-1s, hoping for long-term health savings, rising prices are forcing a ...

Express Scripts — Cigna's pharmacy benefit manager — said Thursday that it will expand low-copay access to GLP-1 agonist weight-loss drugs for participants in some of the prescription drug ...